Walleye Capital LLC Athenex, Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.79 - $1.59 $14,153 - $28,486
-17,916 Closed
0 $0
Q4 2021

Mar 03, 2022
BUY
$1.36 - $2.94 $24,365 - $52,673
17,916 New
17,916 $24,000
Q3 2021

Nov 15, 2021
SELL
$2.97 - $4.84 $57,326 - $93,421
-19,302 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$3.71 - $5.13 $305,882 - $422,958
-82,448 Reduced 81.03%
19,302 $89,000
Q1 2021

May 17, 2021
BUY
$4.08 - $14.75 $415,140 - $1.5 Million
101,750 New
101,750 $438,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email